Azkarra Therapeutics
PrivateLast Round
Seed
Jun 1, 2020
Company Overview
Azkarra Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Seed round in June 2020.
Azkarra Therapeutics is a biotechnology company that develops next-generation DNA damage response-modulating small molecule therapeutics for cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azkarra Therapeutics Comparables
Compare Azkarra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nodus Oncology | 86% | |
| 858 Therapeutics | 82% | |
| FoRx Therapeutics | 82% |
For institutional investors. Book with your work email.
Azkarra Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Azkarra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ShangPharma Innovation | Seed |
| Pandect Bioventures | Seed |
Azkarra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Azkarra Therapeutics's valuation, stock price, and market status.
Is Azkarra Therapeutics a public or private company?
Azkarra Therapeutics is a private company.
What is the current stock price of Azkarra Therapeutics?
Azkarra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Azkarra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Azkarra Therapeutics worth (valuation)?
Valuation information for Azkarra Therapeutics is not publicly available.
Can I buy Azkarra Therapeutics stock?
Azkarra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Azkarra Therapeutics's last funding round?
Azkarra Therapeutics's most recent funding round was Seed on June 1, 2020.
Who are the main investors in Azkarra Therapeutics?
Key investors in Azkarra Therapeutics include Pandect Bioventures.
Will Azkarra Therapeutics IPO soon?
No public IPO plans have been announced for Azkarra Therapeutics.
How can I track Azkarra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Azkarra Therapeutics's shares on secondary markets.